Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001012975-13-000166
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-08 17:26:02
Reporting Period:
2013-05-06
Filing Date:
2013-05-08
Accepted Time:
2013-05-08 17:26:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1262104 Mei Pharma Inc. MEIP Pharmaceutical Preparations (2834) 510407811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192212 O. Philippe Chambon C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1231092 James Niedel C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1247851 Ronald Hunt C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1340806 K Vijay Lathi C/o New Leaf Ventures
2500 Sand Hill Road, Suite 203
Menlo Park CA 94025
No No Yes No
1441439 New Leaf Ventures Ii, L.p. C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1441563 Jeani Delagardelle C/o New Leaf Ventures
2500 Sand Hill Road, Suite 203
Menlo Park CA 94025
No No Yes No
1441857 New Leaf Venture Management Ii, L.l.c. C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1441858 New Leaf Venture Associates Ii, L.p. C/o New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-06 100,000 $8.70 2,145,475 No 4 S Direct
Common Stock Disposition 2013-05-08 100,000 $8.45 2,045,475 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The securities are directly held by New Leaf Ventures II, L.P. ("NLV II") and indirectly held by New Leaf Venture Associates II, L.P. ("NLV Associates II"), the sole general partner of NLV II, New Leaf Venture Management II, L.L.C. ("NLV Management II"), the sole general partner of NLV Associates II, and the individual managers of NLV Management II (NLV Associates II, NLV Management II and the individual managers of NLV Management II each, an "Indirect Reporting Person"). The individual managers of NLV Management II filing jointly with NLV II, NLV Associates II and NLV Management II are Philippe O. Chambon, James Niedel, Ronald Hunt, Vijay Lathi and Jeani Delagardelle. Each Indirect Reporting Person disclaims beneficial ownership of such portion of the NLV II shares in which such Indirect Reporting Person has no actual pecuniary interest therein.